Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant for Postoperative Delirium in Elderly Patients
NCT07695285Phase 2Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Sep 2026
- Primary completion
- Sep 2029
01
Overview
Phase 2, randomised, double-blind trial in postoperative delirium (POD) comparing Lemborexant with Placebo (2 arms). Primary endpoint: Incidence of Postoperative Delirium. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
lemborexant
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT07695285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07695285.